Parnassus Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $762M | Sell |
1,711,440
-61,278
| -3% | -$27.3M | 1.76% | 19 |
|
2025
Q1 | $859M | Sell |
1,772,718
-43,232
| -2% | -$21M | 2.07% | 16 |
|
2024
Q4 | $731M | Buy |
+1,815,950
| New | +$731M | 1.62% | 22 |
|
2024
Q1 | – | Sell |
-738
| Closed | -$300K | – | 142 |
|
2023
Q4 | $300K | Buy |
738
+74
| +11% | +$30.1K | ﹤0.01% | 130 |
|
2023
Q3 | $231K | Buy |
664
+50
| +8% | +$17.4K | ﹤0.01% | 136 |
|
2023
Q2 | $216K | Sell |
614
-152
| -20% | -$53.5K | ﹤0.01% | 133 |
|
2023
Q1 | $241K | Sell |
766
-239,515
| -100% | -$75.5M | ﹤0.01% | 133 |
|
2022
Q4 | $69.4M | Sell |
240,281
-21,686
| -8% | -$6.26M | 0.17% | 91 |
|
2022
Q3 | $75.9M | Hold |
261,967
| – | – | 0.2% | 85 |
|
2022
Q2 | $73.8M | Sell |
261,967
-309,518
| -54% | -$87.2M | 0.18% | 95 |
|
2022
Q1 | $149M | Sell |
571,485
-47,953
| -8% | -$12.5M | 0.3% | 75 |
|
2021
Q4 | $136M | Hold |
619,438
| – | – | 0.26% | 79 |
|
2021
Q3 | $112M | Hold |
619,438
| – | – | 0.24% | 85 |
|
2021
Q2 | $125M | Buy |
+619,438
| New | +$125M | 0.27% | 81 |
|